Cargando…

Emotional barriers and facilitators of deprescribing for older adults with cancer and polypharmacy: a qualitative study

PURPOSE: To describe emotional barriers and facilitators to deprescribing (the planned reduction or discontinuation of medications) in older adults with cancer and polypharmacy. METHODS: Virtual focus groups were conducted over Zoom with 5 key informant groups: oncologists, oncology nurses, primary...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramsdale, Erika, Malhotra, Arul, Holmes, Holly M., Zubkoff, Lisa, Wang, Jinjiao, Mohile, Supriya, Norton, Sally A., Duberstein, Paul R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581937/ https://www.ncbi.nlm.nih.gov/pubmed/37847423 http://dx.doi.org/10.1007/s00520-023-08084-9

Ejemplares similares

CONSIDERATIONS OF AGE-FRIENDLY 4M PRINCIPLES IN DEPRESCRIBING INTERVENTIONS: A SCOPING REVIEW
por: Wang, Jinjiao, et al.
Publicado: (2022)

Polypharmacy and deprescribing: challenging the old and embracing the new
por: O’Donnell, Lisa Kouladjian, et al.
Publicado: (2022)

Deprescribing in Real Time: Hospitalized Septuagenarian With Polypharmacy
por: Famuyiro, Tolulope, et al.
Publicado: (2023)

Polypharmacy, Potentially Inappropriate Medications, and Drug-Drug Interactions in Vulnerable Older Adults With Advanced Cancer Initiating Cancer Treatment
por: Ramsdale, Erika, et al.
Publicado: (2022)

Family Conferences to Facilitate Deprescribing in Older Outpatients With Frailty and With Polypharmacy: The COFRAIL Cluster Randomized Trial
por: Mortsiefer, Achim, et al.
Publicado: (2023)

Correction to: Polypharmacy and deprescribing: Challenging the old and embracing the new
por: O’Donnell, Lisa Kouladjian, et al.
Publicado: (2022)

Barriers and enablers for deprescribing among older, multimorbid patients with polypharmacy: an explorative study from Switzerland
por: Zechmann, Stefan, et al.
Publicado: (2019)

Barriers and facilitators to deprescribing in primary care: a systematic review
por: Doherty, Alison Jayne, et al.
Publicado: (2020)

Barriers and facilitators to deprescribing of cardiovascular medications: a systematic review
por: Brunner, Laureline, et al.
Publicado: (2022)

Polypharmacy and Medication-Related Problems in Hemodialysis Patients: A Call for Deprescribing
por: Alshamrani, Majed, et al.
Publicado: (2018)

Development and Validation of Nine Deprescribing Algorithms for Patients on Hemodialysis to Decrease Polypharmacy
por: Lefebvre, Melissa J., et al.
Publicado: (2020)

Deprescribing interventions and their impact on medication adherence in community-dwelling older adults with polypharmacy: a systematic review
por: Ulley, Joanna, et al.
Publicado: (2019)

Polypharmacy and medication deprescribing: A survey among multimorbid older adults in Denmark
por: Schiøtz, Michaela L., et al.
Publicado: (2018)

Deprescribing and Polypharmacy for Medicare Beneficiaries Under Guardianship in Long-Term Care Facilities
por: Swenson, Tami
Publicado: (2020)

The effects of in-hospital deprescribing on potential prescribing omission in hospitalized elderly patients with polypharmacy
por: Kaminaga, Miho, et al.
Publicado: (2021)

Educating Homecare Nurses about Deprescribing of Medications to Manage Polypharmacy for Older Adults
por: Sun, Winnie, et al.
Publicado: (2021)

Exploration of Barriers and Facilitators for Deprescribing Opioids and Benzodiazepines to Reduce Older Adult Falls
por: Roberts, Ellen, et al.
Publicado: (2020)

How general practitioners would deprescribe in frail oldest-old with polypharmacy — the LESS study
por: Mantelli, Sophie, et al.
Publicado: (2018)

Knowledge and Attitudes of Student Pharmacists Regarding Polypharmacy and Deprescribing: A Cross-Sectional Study
por: Clark, Collin M., et al.
Publicado: (2020)

A Study on the Perceptions of Korean Older Adult Patients and Caregivers about Polypharmacy and Deprescribing
por: Lee, Han-Gyul, et al.
Publicado: (2022)

Facilitators and Barriers Influencing Antipsychotic Medication Prescribing and Deprescribing Practices in Critically Ill Adult Patients: a Qualitative Study
por: Jaworska, Natalia, et al.
Publicado: (2023)

Barriers and facilitators of successful deprescribing as described by older patients living with frailty, their informal carers and clinicians: a qualitative interview study
por: Peat, George, et al.
Publicado: (2022)

“At 80 I Know Myself”: Embodied Learning and Older Adults’ Experiences of Polypharmacy and Perceptions of Deprescribing
por: Ross, Alison, et al.
Publicado: (2019)

Deprescribing for all: a narrative review identifying inappropriate polypharmacy for all ages in hospital settings
por: Elbeddini, Ali, et al.
Publicado: (2021)

Enhancing deprescribing: A qualitative understanding of the complexities of pharmacist‐led deprescribing in care homes
por: Birt, Linda, et al.
Publicado: (2022)

Deprescribing to reduce polypharmacy: study protocol for a randomised controlled trial assessing deprescribing of anticholinergic and sedative drugs in a cohort of frail older people living in the community
por: Bergler, Ulrich, et al.
Publicado: (2021)

General practitioners’ deprescribing decisions in older adults with polypharmacy: a case vignette study in 31 countries
por: Jungo, Katharina Tabea, et al.
Publicado: (2021)

Deprescribing Leads to Improved Energy Intake among Hospitalized Older Sarcopenic Adults with Polypharmacy after Stroke
por: Matsumoto, Ayaka, et al.
Publicado: (2022)

Teaching Deprescribing and Combating Polypharmacy in the Pharmacy Curriculum: Educational Recommendations from Thematic Analysis of Focus Groups
por: Scott, Devin, et al.
Publicado: (2023)

Deprescribing anticholinergic and sedative medicines: protocol for a Feasibility Trial (DEFEAT-polypharmacy) in residential aged care facilities
por: Ailabouni, Nagham, et al.
Publicado: (2017)

Foreword to the first special collection: Addressing the invisible iatrogenic epidemic: the role of deprescribing in polypharmacy and inappropriate medication use
por: Mangin, Dee, et al.
Publicado: (2019)

MediQuit, an Electronic Deprescribing Tool for Patients on Polypharmacy: Results of a Feasibility Study in German General Practice
por: Junius-Walker, Ulrike, et al.
Publicado: (2021)

LESS-PHARMA Study: Identifying and Deprescribing Potentially Inappropriate Medication in the Elderly Population with Excessive Polypharmacy in Primary Care
por: Reus, Xisco, et al.
Publicado: (2022)

Polypharmacy With High Drug Burden Index (DBI) Alters the Gut Microbiome Overriding Aging Effects and Is Reversible With Deprescribing
por: Gemikonakli, Gizem, et al.
Publicado: (2022)

Polypharmacy Prevalence and Perceptions of Deprescribing in Elderly Patients Among Community Primary Care Providers in Mid-Michigan Practices
por: Zreik, Jad, et al.
Publicado: (2023)

Deprescribing as an Opportunity to Facilitate Patient-Centered Care: A Qualitative Study of General Practitioners and Pharmacists in Japan
por: Ie, Kenya, et al.
Publicado: (2023)

The Barriers and Facilitators of Different Stakeholders When Deprescribing Benzodiazepine Receptor Agonists in Older Patients—A Systematic Review
por: Rasmussen, Anja Fog, et al.
Publicado: (2021)

Characteristics of elderly patients with polypharmacy who refuse to participate in an in-hospital deprescribing intervention: a retrospective cross-sectional study
por: Komagamine, Junpei, et al.
Publicado: (2018)

Deprescribing Anticholinergic and Sedative Drugs to Reduce Polypharmacy in Frail Older Adults Living in the Community: A Randomized Controlled Trial
por: Jamieson, Hamish, et al.
Publicado: (2023)

Evaluation of physicians’ knowledge of deprescribing, deprescribing tools and assessment of factors affecting deprescribing process
por: Akande-Sholabi, Wuraola, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vqu5jq904g8uc21sm7n5sg70se